Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Catechol-based polyphenols via metal coordination, commonly referred to as metal-phenolic networks (MPNs), represent a class of supramolecular materials formed by the rapid self-assembly of polyphenolic ligands and various metal ions (Ejima et al., 2013). These systems are not biological targets such as receptors or enzymes; instead, they serve as versatile platforms for drug delivery, bioimaging, and surface engineering (Rahim et al., 2016). The coordination between catechol or galloyl groups and metal ions like Fe3+, Al3+, or Zn2+ allows for the formation of thin films or nanoparticles that are inherently pH-responsive, disassembling in acidic environments to facilitate targeted drug release (Guo et al., 2014). Biologically, these assemblies leverage the natural antioxidant, anti-inflammatory, and antimicrobial properties of polyphenols such as tannic acid or epigallocatechin gallate (EGCG) (Wang et al., 2019). They are frequently employed in nanomedicine to encapsulate diverse therapeutic cargo, including small molecules, proteins, and nucleic acids, to improve their stability and bioavailability (Ping et al., 2015). Consequently, they are extensively researched for applications in oncology, wound healing, and the treatment of chronic inflammatory conditions.
These assemblies function as pH-responsive delivery vehicles that remain stable at physiological pH but disassemble in acidic environments (such as the tumor microenvironment or lysosomes) to release encapsulated therapeutic agents. They also exhibit intrinsic therapeutic effects by utilizing the redox activity of phenolic groups to scavenge reactive oxygen species (ROS) and inhibit oxidative damage.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Catechol-based polyphenols via metal coordination (MPNs).